MedTrace Logo

The Kanyakla Study: a Microclinic Social Network Intervention for Promoting Engagement and Retention in HIV Care

NCT02474992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 304

Last updated 2019-08-08

No results posted yet for this study

Summary

The purpose of this randomized controlled trial is to compare a social network-based behavioral intervention known as microclinics to standard HIV clinical care alone in helping patients receiving HIV care on Mfangano, Remba and Ringiti Islands, Kenya remain adherent to clinic appointments. The study is designed to evaluate the effectiveness of microclinics on reducing gaps in clinical care, HIV viral load and HIV-related stigma, compared to standard HIV clinical care alone. By doing this research study, the investigators hope to learn whether microclinics are a useful social strategy for improving delivery of HIV treatment in rural Kenya.

Conditions

Interventions

BEHAVIORAL

Microclinic

Individuals randomized to this arm will be invited to recruit members of their social network to form a health team, or microclinic. These groups will proceed through a discussion-based health education curriculum led by local community health workers. Topics will include HIV biology, medications, the importance of social support, and community outreach for reducing HIV stigma. The curriculum will conclude with an opportunity for all group members to disclose their HIV status to one another.

Sponsors & Collaborators

Principal Investigators

  • Craig R Cohen, MD, MPH · University of California, San Francisco

  • Elizabeth A Bukusi, MBChB, M.Med, PhD · Kenya Medical Research Institute

  • Matthew D Hickey, MD · University of California, San Francisco

  • Charles R Salmen, MD, MPhil · Organic Health Response

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Kenya

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02474992 on ClinicalTrials.gov